Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.
The whole 16 pages article is available for download here.
Arthritis, an inflammation of the joints, is usually a chronic disease that results from dysregulation of pro-inflammatory cytokines (e.g. tumour necrosis factor and interleukin-1b) and pro-inflammatory enzymes that mediate the production of prostaglandins (e.g. cyclooxygenase-2) and leukotrienes
(e.g. lipooxygenase), together with the expression of adhesion molecules and matrix metalloproteinases, and hyperproliferation of synovial fibroblasts. All of these factors are regulated by the activation of the transcription factor nuclear factor-kB. Thus, agents that suppress the expression of tumour necrosis factor-a, interleukin-1b, cyclooxygenase-2, lipooxygenase, matrix metalloproteinases or adhesion molecules, or suppress the activation of NF-kB, all have potential for the treatment of arthritis.
The whole 8 pages article is available for download here.
Nanoparticles (NP) are defined as particles with a diameter smaller than 100 nm, are increasingly used in different applications, including drug carrier systems and to pass organ barriers such as the blood-brain barrier. Because of their unique properties Nanocrystals (quantum dots) and other nanoparticles (gold colloids, nanobars, dendrimers and nanoshells) have been receiving a lot of attention for potential use in Therapeutics, Bioengineering and therapeutics drug discovery.
The whole 17 pages article is available for download here.
Conference: January 13th & 14th, 2021 (London, UK)
Event will bring you the key insights you need to grow and enhance your pre-filled syringes portfolio and discover what the future holds for the PFS and combination products industry.
Conference: October 7th, 2020 (ONLINE, WEBINAR)
The pulsed X-ray detection module from HEUFT identifies numerous safety and integrity defects of pre-fillable syringes after the caps have been applied with unrivaled low radiation. The HEUFT Syringer detects non-conformities that would normally be invisible to a camera system such as needle shields (both SNS & RNS) pierced by the hypodermic needle, deformed cannulas or incorrectly assembled, defective or leaking luer-lock screw adapters and tamper evident closures of disposable syringes.
Conference: September 27th - 28th, 2021 (Porto, Portugal)
The BioTech Pharma Summit will bring together the movers and shakers in pharma industry from several areas. Uniting niche and top buyers and sellers together under one roof in one event location.
